RecruitingNot ApplicableNCT05152264

Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain

High Frequency, High Intensity Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain - a Randomized Controlled Trial


Sponsor

Göteborg University

Enrollment

40 participants

Start Date

Nov 12, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The study evaluates the effect of TENS (transcutaneous electrical nerve stimulation) as add-on treatment compared with conventional analgesic treatment in patients with endometriosis-related chronic pain. Patients with frequent pain and high pain intensity will be randomized to additional treatment with TENS or conventional treatment for 8 weeks to evaluate the acute effects of TENS treatment (n=40). Patients with endometriosis-related pain that is not frequent or without high pain intensity constitute an external control group. All patients in the study will receive TENS treatment for a total of 16 weeks, for evaluation of long-term effects of TENS treatment.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 100 Years

Inclusion Criteria5

  • Age ≥18 years
  • Consents to participation in the study
  • Verified endometriosis (by laparoscopy or ultrasound).
  • Chronic endometriosis-related pain (\> 3 months), available for TENS treatment
  • Functioning, stable endometriosis-specific hormonal drug therapy. The endometriosis-specific drug therapy must be unchanged for the last 3 months and no gynecological surgical procedures for the treatment of endometriosis are planned during the next 7 months (during study participation). The endometriosis-specific drug therapy does not refer to analgesic therapy for symptom relief of endometriosis-related pain.

Exclusion Criteria10

  • Patient with inability to understand and use written and spoken Swedish
  • Patient with pacemaker and/or ICD or other electronic implants
  • Patient with impaired sensation over the painful area
  • Malignant disease with an expected survival \<12 months
  • Alcohol or substance abuse
  • Serious untreated psychiatric illness and/or psychological condition that is the primary determinant of the patient's condition
  • Participating in another intervention study with possible impact on current study outcome measures
  • Patient who is using \>90 morphine equivalents/day
  • Patient who is electro-acupuncture
  • Pregnancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscutaneous electrical nerve stimulation (TENS)

Treatment with transcutaneous electrical nerve stimulation (TENS) during 16 weeks.

OTHERConventional analgesic treatment

Conventional analgesic treatment. Conventional analgesic treatment may include no pharmacological treatment if the patient does not use any analgesics.


Locations(1)

Pain Centre, Department of Anaesthesiology and Intensive Care Medicine Östra, Sahlgrenska University Hospital, Region Västra Götaland

Gothenburg, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05152264


Related Trials